← SearchRetroviral Vectors for Safe and Efficacious Gene Therapy$209,395R42FY2006RRNIHNeumedicines, Inc., Pasadena CAInvestigatorsPaula M CannoncontactLinked publications & trialsPaper 17767401View original record on NIH RePORTER →